Re: Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial

European Urology ◽

10.1016/j.eururo.2016.08.064 ◽

2017 ◽

Vol 71 (2) ◽

pp. 301-302

Author(s):

Rafael Sanchez-Salas

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Laser Ablation ◽

Phase I ◽

Phase I Clinical Trial

Download Full-text

Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial

The Journal of Urology ◽

10.1016/j.juro.2015.12.083 ◽

2016 ◽

Vol 196 (1) ◽

pp. 68-75 ◽

Author(s):

Shyam Natarajan ◽

Steven Raman ◽

Alan M. Priester ◽

James Garritano ◽

Daniel J.A. Margolis ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Laser Ablation ◽

Phase I ◽

Phase I Clinical Trial

Download Full-text

Faculty Opinions recommendation of Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1118816.793494158 ◽

2014 ◽

Author(s):

Thomas Flaig

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Phase I ◽

Abiraterone Acetate ◽

Selective Inhibitor ◽

Phase I Clinical Trial ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

A Phase I Clinical Trial of CD1c (BDCA-1)+ Dendritic Cells Pulsed With HLA-A*0201 Peptides for Immunotherapy of Metastatic Hormone Refractory Prostate Cancer

Journal of Immunotherapy ◽

10.1097/cji.0000000000000063 ◽

2015 ◽

Vol 38 (2) ◽

pp. 71-76 ◽

Author(s):

Rebecca L. Prue ◽

Frank Vari ◽

Kristen J. Radford ◽

Hui Tong ◽

Melinda Y. Hardy ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Dendritic Cells ◽

Phase I ◽

Phase I Clinical Trial ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

838 Magnetic resonance imaging-guided transurethral ultrasound prostate ablation in patients with localized prostate cancer: 12-Month outcomes of a prospective phase I clinical trial

European Urology Supplements ◽

10.1016/s1569-9056(16)60840-0 ◽

2016 ◽

Vol 15 (3) ◽

pp. e838

Author(s):

M. Billia ◽

S. Pahernik ◽

J. Relle ◽

I.V. Popeneciu ◽

T. Kuru ◽

...

Keyword(s):

Magnetic Resonance Imaging ◽

Prostate Cancer ◽

Clinical Trial ◽

Magnetic Resonance ◽

Phase I ◽

Phase I Clinical Trial ◽

Localized Prostate Cancer ◽

Resonance Imaging ◽

Prospective Phase ◽

Transurethral Ultrasound

Download Full-text

Vaccination of metastatic prostate cancer patients using mature dendritic cells transfected with mRNA encoding hTERT or an MHC class II targeted hTERT/LAMP fusion protein: Results from a phase I clinical trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.2507 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 2507-2507

Author(s):

Z. Su ◽

J. W. Vieweg ◽

J. Dannull ◽

P. Dahm

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Dendritic Cells ◽

Fusion Protein ◽

Phase I ◽

Cancer Patients ◽

Mhc Class Ii ◽

Metastatic Prostate Cancer ◽

Class Ii ◽

Phase I Clinical Trial

Download Full-text

Re: Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms that Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven

European Urology ◽

10.1016/j.eururo.2008.09.035 ◽

2009 ◽

Vol 55 (1) ◽

pp. 248

Author(s):

Mario A. Eisenberger

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Phase I ◽

Abiraterone Acetate ◽

Selective Inhibitor ◽

Phase I Clinical Trial ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Phase I clinical trial of interleukin 2 (IL-2) gene therapy for prostate cancer

Current Urology Reports ◽

10.1007/s11934-001-0019-7 ◽

2001 ◽

Vol 2 (1) ◽

pp. 9-9 ◽

Author(s):

Allan J. Pantuck ◽

Arie S. Belldegrun

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Gene Therapy ◽

Phase I ◽

Interleukin 2 ◽

Phase I Clinical Trial

Download Full-text

Preclinical profile and phase I clinical trial of a novel androgen receptor antagonist GT0918 in castration-resistant prostate cancer

European Journal of Cancer ◽

10.1016/j.ejca.2020.04.013 ◽

2020 ◽

Vol 134 ◽

pp. 29-40 ◽

Author(s):

Tie Zhou ◽

Weidong Xu ◽

Wei Zhang ◽

Ye Sun ◽

Honghua Yan ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Androgen Receptor ◽

Phase I ◽

Receptor Antagonist ◽

Phase I Clinical Trial ◽

Castration Resistant Prostate Cancer ◽

Androgen Receptor Antagonist ◽

Castration Resistant

Download Full-text

UP-2.169: A Phase I Clinical Trial of In Situ Gene Therapy with Radioiodine for Locally Recurrent Prostate Cancer Following External Beam Radiotherapy

Urology ◽

10.1016/j.urology.2009.07.388 ◽

2009 ◽

Vol 74 (4) ◽

pp. S285

Author(s):

T. Wilson ◽

B. Davis ◽

G. Wiseman ◽

M. Federspiel ◽

D. Tindall ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Gene Therapy ◽

Phase I ◽

External Beam Radiotherapy ◽

Phase I Clinical Trial ◽

External Beam ◽

Recurrent Prostate Cancer ◽

Locally Recurrent

Download Full-text

Faculty Opinions recommendation of Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1118816.574906 ◽

2008 ◽

Author(s):

John Amory

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Phase I ◽

Abiraterone Acetate ◽

Selective Inhibitor ◽

Phase I Clinical Trial ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text